{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:25:55Z","timestamp":1785594355398,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.diabres.2021.108859","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T22:08:34Z","timestamp":1620770914000},"page":"108859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes"],"prefix":"10.1016","volume":"176","author":[{"given":"Arnaud D.","family":"Kaze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Santhanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebhat","family":"Erqou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain G.","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rexford S.","family":"Ahima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Echouffo-Tcheugui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108859_b0005","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108859_b0010","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc07-0264","article-title":"Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study","volume":"30","author":"Cheung","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108859_b0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc06-1747","article-title":"Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women","volume":"30","author":"Juutilainen","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108859_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2011.06.029","article-title":"Does microvascular disease predict macrovascular events in type 2 diabetes?","volume":"218","author":"Rosenson","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2021.108859_b0025","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.jacc.2019.03.002","article-title":"Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes","volume":"73","author":"Verma","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108859_b0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108859_b0035","doi-asserted-by":"crossref","first-page":"1631263","DOI":"10.1155\/2018\/1631263","article-title":"Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration","volume":"2018","author":"Seferovic","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2021.108859_b0040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","article-title":"Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study","volume":"4","author":"Brownrigg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2021.108859_b0045","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108859_b0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0197-2456(03)00064-3","article-title":"Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes","volume":"24","author":"Ryan","year":"2003","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.diabres.2021.108859_b0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3132\/dvdr.2006.031","article-title":"Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study","volume":"3","author":"Group LAR","year":"2006","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.diabres.2021.108859_b0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2021.108859_b0065","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108859_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","article-title":"Enzymatic methods for quantification of lipoprotein lipids","volume":"129","author":"Warnick","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.diabres.2021.108859_b0075","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2021.108859_b0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2021.108859_b0085","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1464-5491.2007.02145.x","article-title":"Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus","volume":"24","author":"Tong","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108859_b0090","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1464-5491.2008.02592.x","article-title":"Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16","volume":"25","author":"Yokoyama","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108859_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2840-6-37","article-title":"Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry","volume":"6","author":"Yang","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2021.108859_b0100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-007-0616-1","article-title":"Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study","volume":"50","author":"Bruno","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108859_b0105","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jacc.2004.09.006","article-title":"Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria","volume":"44","author":"Knobler","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108859_b0110","doi-asserted-by":"crossref","unstructured":"Jeganathan VSE, Cheung N, Wong Y. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med 2008;25:882; author reply 882-3. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02457.x.","DOI":"10.1111\/j.1464-5491.2008.02457.x"},{"key":"10.1016\/j.diabres.2021.108859_b0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8227(02)00128-6","article-title":"Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes","volume":"58","author":"Wheeler","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2021.108859_b0120","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1464-5491.2008.02567.x","article-title":"Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study","volume":"25","author":"Ko","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108859_b0125","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc06-2558","article-title":"Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location","volume":"30","author":"Avogaro","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108859_b0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabres.2021.108859_b0135","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000020091.07144.C7","article-title":"UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine","volume":"33","author":"Kothari","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.diabres.2021.108859_b0140","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ije\/dyi060","article-title":"Proper interpretation of non-differential misclassification effects: expectations vs observations","volume":"34","author":"Jurek","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.diabres.2021.108859_b0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.xkme.2020.10.005","article-title":"Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk","volume":"3","author":"Gil","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.diabres.2021.108859_b0150","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jacc.2007.06.027","article-title":"Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria","volume":"50","author":"Cortigiani","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:17:41Z","timestamp":1759173461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721002187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"alternative-id":["S0168822721002187"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108859","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108859"}}